Saturday, September 26, 2026
MiningNewsTerminal
Saturday, September 26, 2026 Admin

BAC.CN ·

BacTech Receives 99% Gold Recovery from Bioleach Test Work on Ecuador Feedstocks

Metallurgy & Processing

BacTech Receives 99% Gold Recovery from Bioleach Test Work on

Ecuador Feedstocks

TORONTO, ON., April 21, 2021 – BacTech Environmental Corporation (OTC:BCCEF,

CSE:BAC)(“BacTech or the Company”), a commercially proven environmental technology

company delivering effective and eco-friendly biomining and remediation solutions, today is

pleased to announce what the Company considers to be very positive gold recovery results

from the third-party diagnostic test work being conducted at ALS Laboratories in Perth,

Australia under the guidance of BacTech’s Dr. Paul Miller. ALS Laboratories is a recognized

global leader in metallurgical testing and consulting services for mineral process flowsheet

development and optimization.

Concentrated samples of arsenopyrite and pyrite material collected from small mine producers

in Ponce Enriquez, Ecuador, previously assayed to confirm positive magnitudes of gold, were

subjected to diagnostic leaching as part of a larger program of bioleach testing. Diagnostic

testing provides a rapid and early determination of the magnitude of gold recovery anticipated

from a commercial bioleach process and whether the project should be pursued. Results

received from ALS Laboratories on 20 April confirmed that all the gold in a blend of two

Ecuadorian feedstocks subjected to diagnostic leaching was associated with minerals amenable

to bioleaching giving a 100% gold recovery. Results from diagnostic leach testing of a further

Ecuadorian feedstock returned a value of 99.4% gold recovery.

“BacTech is pleased to report that the much-anticipated diagnostic test results returned

excellent gold liberation values confirming a refractory mineralogy highly amenable to bioleach

processing,” said Ross Orr, President and CEO of BacTech. “Waiting for test results is never

easy, but after two months of diagnostic test work, the anticipated gold recoveries give us the

confidence to move forward to the next step. In short, this confirms operational viability.”

The Company and ALS continue with the formal bioleach test work with respect to bio-

oxidation kinetics; arsenic neutralization and gold recovery to obtain the necessary criteria to

move forward with plant design. The Company anticipates that a site will be selected near

Ponce Enriquez to host the proposed plant in the near future and will subsequently begin the

permitting process which requires extensive lead time when compared to other aspects of the

project.

Following the overall study completion, the Company will award a third-party Feasibility Study

to determine the economic potential of the project. It should be noted that this study is

expected to be simplified by the fact that there are no mining requirements to consider.

Pending project feasibility, a Detailed Engineering Study would then be commissioned. It is

anticipated a Chief Operating Officer responsible for building out the bioleach plant will be

engaged shortly. BacTech will provide the market with updates in due course.

“Subject to travel restrictions, my plan is to visit Ponce soon to identify a suitable location for

this plant,” Orr added. “Although the footprint for our planned bioleaching facility will be small

compared to the total acreage we’re seeking, we envision a need for a sizable material storage

area and capacity for up to, what we hope will be, 20 years of processing material from Ponce

and beyond. Once a plant is established, we anticipate attracting more suppliers of feedstocks

and will aim to make provision at the design stage to allow expansion of the initial plant and

give greater economies of scale.”

The selection of Ponce Enriquez is driven by the extremely high levels of arsenic that are

associated with gold in the +90 small mines in the area which attract high penalties in smelting.

Presently, the miners are forced to sell their production at reduced prices to offshore buyers

due to the high arsenic values in the concentrates, and consequently accept lower financial

returns. By eliminating financial penalties charged for arsenic, BacTech proposes to pay better

prices for the miners’ material.

This press release has been reviewed by Dr Paul C. Miller Ph.D Chem. Eng. C.Eng. MIMM.,

considered a qualified expert for reporting purposes.

About BacTech Environmental Corporation

BacTech is a proven environmental technology company, delivering effective and eco-friendly

biomining and remediation solutions to commercial operations to smartly process and recover

preferred metals (gold, silver, cobalt, and copper) and safely remove and transform harmful

contaminants like arsenic into benign EPA-approved products for landfill. Tapping into

numerous environmental and economic advantages of its proprietary method of bioleaching,

BacTech uses naturally-occurring bacteria, harmless to both humans and the environment, to

neutralize toxic mining sites with high-pay potential.

BacTech is in early discussions to build its new owner-operated bioleaching facility in Ponce

Enriquez, Ecuador where arsenic is well-known to exist alongside gold mining and is

investigating the prospects of establishing additional modern mining operations across other

areas of Ecuador, Peru, Colombia, and Central America. Where possible, the Company will

partner with national and local governments, non-governmental organizations (NGOs), and

others to assist with the funding of these projects. BacTech is publicly traded on the CSE under

the symbol “BAC” and on the OTC as “BCCEF”.

For further information contact:

Ross Orr,

President & CEO, BacTech Environmental Corporation

416-813-0303 ext. 222,

Email: [email protected]

Website: www.bactechgreen.com

Follow us on:

Facebook http://www.facebook.com/BacTechGreen

Twitter http://twitter.com/BacTechGreen

LinkedIn http://www.linkedin.com/company/1613873

Vimeo http://vimeo.com/bactechgreen

YouTube http://www.youtube.com/user/bactechgreen

Special Note Regarding Forward-Looking Statements

This news release contains “forward-looking information”, which may include, but is not limited

to, statements with respect to future tailings sites, sampling or other investigations of tailing

sites, the Company’s ability to make use of infrastructure around tailings sites or operating

performance of the Company and its projects. Often, but not always, forward-looking

statements can be identified using words such as “plans”, “expects”, “is expected”, “budget”,

“scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or believes” or variations

(including negative variations) of such words and phrases, or state that certain actions, events

or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-

looking statements involve known and unknown risks, uncertainties and other factors which

may cause the actual results, performance or achievements of the Company to be materially

different from any future results, performance or achievements expressed or implied by the

forward-looking statements. Forward-looking statements contained herein are made as of the

date of this news release and the Company disclaims, other than as required by law, any

obligation to update any forward-looking statements whether because of new information,

results, future events, circumstances, or if management’s estimates or opinions should change,

or otherwise. There can be no assurance that forward-looking statements will prove to be

accurate, as actual results and future events could differ materially from those anticipated in

such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-

looking statements.

Shares outstanding: 135,723,871

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility

for the adequacy or the accuracy of the contents of this release.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of

the shares, nor is it a solicitation of interest from a prospective investor.